BRITISH AMERICAN TOBACCO PLC (BTI)

NYSEConsumer StaplesTobaccoSnapshot 2026-10-23

$59.48-1.64%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge BRITISH AMERICAN TOBACCO PLC’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	13.93B
EPS	—	1.957
Annual ending 2026-12-31
Revenue	—	26.27B
EPS	—	3.627
Annual ending 2027-12-31
Revenue	—	27.23B
EPS	—	3.899

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
maintain market share against nicotine pouch competition	A primary condition in BRITISH AMERICAN TOBACCO PLC's published investment case. The stated target is stable or growing market share in key segments by FY27.	Intact	market share declines significantly due to nicotine pouch competition	Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
successful cost cutting and restructuring	A primary condition in BRITISH AMERICAN TOBACCO PLC's published investment case. The stated target is cost savings sufficient to stabilize margins and earnings by FY27.	Improving	cost cuts fail to improve margins or earnings by FY27	Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
earnings per share (EPS) for FY26 and FY27	Analysts expect earnings per share near $4.84 in 2026 and $5.25 in 2027.	Intact	EPS falls below $4.84 in FY26 or below $5.25 in FY27	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
growth in partnership revenues such as ITC	A supporting condition in BRITISH AMERICAN TOBACCO PLC's published investment case. The stated target is >= 10% revenue growth from partnerships in FY27.	Intact	partnership revenues decline or grow less than 5% in FY27	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPSUnavailable

$5.23 → Unavailable · observed estimates

FY2027 revenue$27.23B

$27.23B → $27.23B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$5.23	$27,234,101,540	5 / 13
2026-07-25	Unavailable	$27,015,801,583	4 / 7
2026-07-26	$5.23	$27,234,101,540	5 / 13
2026-07-27	$5.23	$27,234,101,540	5 / 13
2026-07-28	$5.23	$27,234,101,540	5 / 13
2026-07-29	$5.23	$27,234,101,540	5 / 13
2026-07-30	$5.23	$27,234,101,540	5 / 13
2026-07-31	$5.23	$27,234,101,540	5 / 13
2026-08-01	Unavailable	$27,062,178,679	4 / 8
2026-08-02	$5.22	$27,219,985,190	5 / 13
2026-08-03	$5.22	$27,165,840,880	5 / 14
2026-08-04	$5.22	$27,165,840,880	5 / 14
2026-08-05	$5.22	$27,165,840,880	5 / 14
2026-08-06	$5.22	$27,158,014,370	5 / 15
2026-08-07	Unavailable	$27,072,614,852	4 / 8
2026-08-08	$5.22	$27,166,252,040	5 / 15
2026-08-09	$5.22	$27,166,252,040	5 / 15
2026-08-10	$5.22	$27,166,252,040	5 / 15
2026-08-11	Unavailable	$27,072,614,852	4 / 8
2026-08-12	$5.22	$27,166,585,380	5 / 15
2026-08-13	Unavailable	$27,072,614,852	4 / 8
2026-08-14	Unavailable	$27,072,614,852	4 / 8
2026-08-15	Unavailable	$27,072,614,852	4 / 9
2026-08-16	Unavailable	$27,072,614,852	4 / 9
2026-08-17	Unavailable	$27,072,614,852	4 / 9
2026-08-18	Unavailable	$27,072,614,852	4 / 9
2026-08-19	Unavailable	$27,072,614,852	4 / 9
2026-08-20	Unavailable	$27,110,120,445	4 / 9
2026-08-21	Unavailable	$27,110,120,445	4 / 9
2026-08-22	Unavailable	$27,110,120,445	4 / 9
2026-08-23	Unavailable	$27,110,120,445	4 / 9
2026-08-24	Unavailable	$27,110,120,445	4 / 9
2026-08-25	Unavailable	$27,110,120,445	4 / 9
2026-08-26	Unavailable	$27,110,120,445	4 / 9
2026-08-27	Unavailable	$27,110,120,445	4 / 9
2026-08-28	Unavailable	$27,110,120,445	4 / 9
2026-08-29	Unavailable	$27,105,613,256	4 / 9
2026-08-30	Unavailable	$27,104,280,328	4 / 9
2026-08-31	Unavailable	$27,104,280,328	4 / 9
2026-09-01	Unavailable	$27,104,280,328	4 / 9
2026-09-02	Unavailable	$27,104,280,328	4 / 9
2026-09-03	Unavailable	$27,090,255,220	4 / 9
2026-09-04	Unavailable	$27,098,250,469	4 / 9
2026-09-05	Unavailable	$27,113,673,199	4 / 9
2026-09-06	Unavailable	$27,113,673,199	4 / 9
2026-09-07	Unavailable	$27,113,673,199	4 / 9
2026-09-08	Unavailable	$27,109,655,589	4 / 9
2026-09-09	Unavailable	$27,109,655,589	4 / 9
2026-09-10	Unavailable	$27,124,062,429	4 / 9
2026-09-11	Unavailable	$27,146,009,663	4 / 9
2026-09-12	Unavailable	$27,128,694,031	4 / 9
2026-09-13	Unavailable	$27,128,694,031	4 / 9
2026-09-14	Unavailable	$27,128,694,031	4 / 9
2026-09-15	Unavailable	$27,128,694,031	4 / 9
2026-09-16	Unavailable	$27,128,694,031	4 / 9
2026-09-17	Unavailable	$27,128,694,031	4 / 9
2026-09-18	Unavailable	$27,128,694,031	4 / 9
2026-09-19	Unavailable	$27,128,694,031	4 / 9
2026-09-20	Unavailable	$27,104,138,419	4 / 9
2026-09-21	Unavailable	$27,104,138,419	4 / 9
2026-09-22	Unavailable	$27,104,138,419	4 / 9
2026-09-23	Unavailable	$27,104,138,419	4 / 9
2026-09-24	Unavailable	$27,104,138,419	4 / 9
2026-09-25	Unavailable	$27,104,138,419	4 / 9
2026-09-26	Unavailable	$27,104,138,419	4 / 9
2026-09-27	Unavailable	$27,104,138,419	4 / 9
2026-09-28	Unavailable	$27,104,138,419	4 / 9
2026-09-29	Unavailable	$27,104,138,419	4 / 9
2026-09-30	Unavailable	$27,104,138,419	4 / 9
2026-10-01	Unavailable	$27,023,797,450	4 / 9
2026-10-02	Unavailable	$27,023,797,450	4 / 9
2026-10-03	Unavailable	$27,023,797,450	4 / 9
2026-10-04	Unavailable	$27,023,797,450	4 / 9
2026-10-05	Unavailable	$27,023,797,450	4 / 9
2026-10-06	Unavailable	$27,023,797,450	4 / 9
2026-10-07	Unavailable	$27,023,797,450	4 / 9
2026-10-08	Unavailable	$27,023,797,450	4 / 9
2026-10-09	Unavailable	$27,023,797,450	4 / 9
2026-10-10	Unavailable	$27,023,797,450	4 / 9
2026-10-11	Unavailable	$27,023,797,450	4 / 9
2026-10-12	Unavailable	$27,023,797,450	4 / 9
2026-10-13	Unavailable	$27,268,852,636	4 / 9
2026-10-14	Unavailable	$27,268,852,636	4 / 9
2026-10-15	Unavailable	$27,268,852,636	4 / 9
2026-10-16	Unavailable	$27,268,852,636	4 / 9
2026-10-17	Unavailable	$27,268,852,636	4 / 9
2026-10-18	Unavailable	$27,268,852,636	4 / 9
2026-10-19	Unavailable	$27,268,852,636	4 / 9
2026-10-20	Unavailable	$27,268,852,636	4 / 9
2026-10-21	Unavailable	$27,268,852,636	4 / 9
2026-10-22	Unavailable	$27,268,852,636	4 / 9
2026-10-23	Unavailable	$27,231,819,135	4 / 9
2026-10-24	Unavailable	$27,228,261,912	4 / 9

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	5	1	1
2026-06-01	5	1	1
2026-07-01	6	1	0
2026-08-01	6	1	0
2026-09-01	7	1	0
2026-10-01	7	1	0

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 7 Buy / Strong Buy · 1 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

maintain market share against nicotine pouch competitionQualitative condition
successful cost cutting and restructuringQualitative condition
earnings per share (EPS) for FY26 and FY27Direct metric needs a verified mapping
growth in partnership revenues such as ITCDirect metric needs a verified mapping

Next proof point

Next earnings date unavailable

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.0%Typical daily move · historical

Downside history

-21.5%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

BRITISH AMERICAN TOBACCO PLC outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

The evidence is too thin to classify BTI confidently as a durable compounder, cyclical business, or another investment type. The thesis state is marked insufficient because there is not enough recent financial-performance history, and confidence in the overall evidence is low.

What's priced into BRITISH AMERICAN TOBACCO PLC

The snapshot gives no valuation level or market expectations, so it does not support calling BTI cheap, fair, or expensive versus peers. It reports low valuation fragility, meaning no listed warning signal suggests expectations are unusually concentrated.

What the fundamentals likely do

There is not enough recent financial detail here to establish a multi-year fundamental trend. Near term, the stated miss probability is low, but the snapshot also notes misses in recent quarters and a deep miss in recent history; the risk label has risen from low to moderate.

What BRITISH AMERICAN TOBACCO PLC hinges on

A weakening jobs trend could increase recession concerns and weigh on BTI and other consumer staples names. Earnings and guidance from PM, MO, and TPB are also key signals: continued strength could support the sector backdrop, while misses or lower guidance could remove that support.